Thomas Plitz
Director/Board Member bij RELIEF THERAPEUTICS HOLDING SA
Vermogen: 1 804 $ op 31-03-2024
Profiel
Thomas Plitz is currently the Chief Executive Officer at Chord Therapeutics SA and the Vice Chairman at RELIEF THERAPEUTICS Holding SA. Previously, he held positions as Principal at Shire Pharmaceuticals, Inc., Serono Corp., and Merck Serono Ltd.
He also served as the Chief Scientific Officer at Wilson Therapeutics AB.
Dr. Plitz obtained a doctorate degree from Technische Universität München.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 30-04-2023 | 1 250 ( 0.01% ) | 1 804 $ | 31-03-2024 |
Actieve functies van Thomas Plitz
| Bedrijven | Functie | Begin |
|---|---|---|
| RELIEF THERAPEUTICS HOLDING SA | Director/Board Member | 17-12-2020 |
Chord Therapeutics SA
 Chord Therapeutics SA BiotechnologyHealth Technology Chord Therapeutics SA is a clinical stage pharmaceutical company. It develops drugs for patients with rare, life-threatening and severely disabling diseases. The firm offers CRD1. The company was founded by Arthur Roach and is headquartered in Geneva, Switzerland. | Chief Executive Officer | 01-08-2020 |
Eerdere bekende functies van Thomas Plitz
| Bedrijven | Functie | Einde |
|---|---|---|
Merck Serono Ltd.
 Merck Serono Ltd. Miscellaneous Commercial ServicesCommercial Services Merck Serono Ltd. provides research and development services and manufactures medicinal drugs. The company is headquartered in Middlesex, the United Kingdom. | Corporate Officer/Principal | - |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Corporate Officer/Principal | - |
| Serono Corp. | Corporate Officer/Principal | - |
| WILSON THERAPEUTICS AB | Chief Tech/Sci/R&D Officer | - |
Opleiding van Thomas Plitz
| Technische Universität München | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| RELIEF THERAPEUTICS HOLDING SA | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Health Technology |
| Serono Corp. | |
Merck Serono Ltd.
Merck Serono Ltd. Miscellaneous Commercial ServicesCommercial Services Merck Serono Ltd. provides research and development services and manufactures medicinal drugs. The company is headquartered in Middlesex, the United Kingdom. | Commercial Services |
Wilson Therapeutics AB
 Wilson Therapeutics AB Pharmaceuticals: MajorHealth Technology Wilson Therapeutics AB engages in the development of novel therapies for patients with rare copper-mediated disorders. The company was founded on April 25, 2012 and is headquartered in Stockholm, Sweden. | Health Technology |
Chord Therapeutics SA
Chord Therapeutics SA BiotechnologyHealth Technology Chord Therapeutics SA is a clinical stage pharmaceutical company. It develops drugs for patients with rare, life-threatening and severely disabling diseases. The firm offers CRD1. The company was founded by Arthur Roach and is headquartered in Geneva, Switzerland. | Health Technology |
